266 related articles for article (PubMed ID: 19160361)
1. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease.
Frilling A; Li J; Malamutmann E; Schmid KW; Bockisch A; Broelsch CE
Br J Surg; 2009 Feb; 96(2):175-84. PubMed ID: 19160361
[TBL] [Abstract][Full Text] [Related]
2. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
3. Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.
Elias D; Goéré D; Leroux G; Dromain C; Leboulleux S; de Baere T; Ducreux M; Baudin E
Eur J Surg Oncol; 2009 Oct; 35(10):1092-7. PubMed ID: 19464140
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience.
Dejong CH; Parks RW; Currie E; Piris J; Redhead DN; Garden OJ
J R Coll Surg Edinb; 2002 Apr; 47(2):495-9. PubMed ID: 12018694
[TBL] [Abstract][Full Text] [Related]
5. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Auernhammer CJ; Jauch KW; Hoffmann JN
Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
[TBL] [Abstract][Full Text] [Related]
6. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease (Br J Surg 2009; 96: 175-184).
Søreide JA
Br J Surg; 2009 Jul; 96(7):823; author reply 823-4. PubMed ID: 19526606
[No Abstract] [Full Text] [Related]
7. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
[TBL] [Abstract][Full Text] [Related]
8. Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours.
Norlén O; Stålberg P; Zedenius J; Hellman P
Br J Surg; 2013 Oct; 100(11):1505-14. PubMed ID: 24037573
[TBL] [Abstract][Full Text] [Related]
9. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
11. Management of advanced neuroendocrine tumors with hepatic metastasis.
Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
[TBL] [Abstract][Full Text] [Related]
12. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.
Cao CQ; Yan TD; Bester L; Liauw W; Morris DL
Br J Surg; 2010 Apr; 97(4):537-43. PubMed ID: 20205229
[TBL] [Abstract][Full Text] [Related]
13. Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome.
Swärd C; Johanson V; Nieveen van Dijkum E; Jansson S; Nilsson O; Wängberg B; Ahlman H; Kölby L
Br J Surg; 2009 May; 96(5):517-21. PubMed ID: 19358175
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for unresectable neuroendocrine liver metastases.
John BJ; Davidson BR
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
16. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
[TBL] [Abstract][Full Text] [Related]
17. Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think..
Elias D; Lefevre JH; Duvillard P; Goéré D; Dromain C; Dumont F; Baudin E
Ann Surg; 2010 Feb; 251(2):307-10. PubMed ID: 20010089
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
Auernhammer CJ; Göke B
Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
[TBL] [Abstract][Full Text] [Related]
19. [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure].
Olausson M; Friman S; Johanson V; Nilsson O; Wängberg B; Ahlman H
Lakartidningen; 1999 Sep; 96(36):3783-6. PubMed ID: 10500396
[TBL] [Abstract][Full Text] [Related]
20. Liver-directed therapies for metastatic neuroendocrine tumors.
Garrot C; Stuart K
Hematol Oncol Clin North Am; 2007 Jun; 21(3):545-60; ix-x. PubMed ID: 17548039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]